S100A7 and oral cavity squamous cell carcinoma: Trials using a non-invasive approach to examine salivary samples of patients with oral squamous cell carcinoma (OSCC) reported S100A7 overexpression, indicating that salivary S100A7 levels may assist in detecting early stages of this disease (Jou et al., 2014; Dey et al., 2015).